2019 Symposium
|
2018 SymposiumThe 14th Moores Cancer Center Industry/Academia Translational Oncology Symposium was held on Thursday, February 22, 2018. Engineered T-Cells: The Sky is the Limit Carl June, MD Perelman School Of Medicine University Of Pennsylvania Keynote Speaker A New Model for Translational Research in the Nonprofit Sector Peter Schultz, PhD California Institute for Biomedical Research Opening Remarks Ida Deichaite, PhD, UC San Diego Moores Cancer Center Mutational Signatures for Cancer Treatment and Cancer Prevention Ludmil Alexandrov, PhD, UC San Diego Moores Cancer Center Duane Roth Award Presenter David Brenner, MD, Dean, UC San Diego SOM & Health Sciences Junior Scientist Presentation: Dual PI3K/BRD4 Inhibition as a Novel Therapeutic Strategy for Hepatocellular Carcinoma Adam Burgoyne, MD, PhD, UC San Diego Moores Cancer Center The New Generation of Antibody Drug Conjugates: Intersection of Target and Payload Julia Coronella, PhD, Tanabe Research Labs Moores Cancer Center Overview Ezra Cohen, MD, UC San Diego Moores Cancer Center Symposium Introduction Ida Deichaite, PhD, UC San Diego Moores Cancer Center In silico drug discovery of dual inhibitors of combinatorial synthetic lethality inhibitors in the era of precision medical oncology; proof of concept Donald Durden, MD, PhD, UC San Diego Moores Cancer Center Role of neutrophil-mediated inflammation in colorectal cancer Napoleone Ferrara, MD, UC San Diego Moores Cancer Center A Personalized Cancer Immunotherapy Paradigm: Simple solutions to address complex options for patients Priti Hedge, PhD, Genentech The Next Wave: BCMA Targeted CAR-T Cells for Multiple Myeloma Kristen Hege, MD, Celgene Welcome Remarks Pradeep Khosla, PhD, Chancellor, UC San Diego Moores Cancer Center Introduction Scott Lippman, MD, UC San Diego Moores Cancer Center Inhibition of Difficult to Drug Tumor Cell and Immuno-Oncology targets with Next Generation Antisense Inhibitors Robert MacLeod, PhD, Ionis Pharmaceuticals Systematic Mapping of Genetic Vulnerabilities in Cancer via Novel CRISPR-Cas9 Screening Methodologies Prashant Mali, PhD, UC San Diego Moores Cancer Center Patient Advocacy Presentation Brian McCloskey, Patient Advocate Targeting PARP in Prostate Cancer: Promise and Pitfalls Rana McKay, MD, UC San Diego Moores Cancer Center Patient Advocacy Presentation Bryce Olson, Patient Advocate Gene Control Approach to Manipulate Cell State: Sensitizing Cancer Cells to Antibody-mediated Attack Dave Orlando, PhD, Syros Pharmaceuticals Killing Cancer Stem Cells in Brain Cancer Jeremy Rich, MD, UC San Diego Moores Cancer Center 2018 Symposium Featured TalksPlease enjoy the featured talks below from our recent symposium. Thank you! Please note: These videos are for private viewing only. Any unintended use of the videos without consent is prohibited. Keynote Presentation: Duane Roth Award Lecture
|
|